Stay updated on ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFallopian tube cancer was added to the study's conditions, and the page revision was updated to v3.4.2 (v3.4.1 was removed).SummaryDifference0.1%

- Check20 days agoChange DetectedRevision: v3.4.1 replaces Revision: v3.4.0 on the page, which is a minor update to the revision label and does not affect study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a glossary display, the 'Last Update Submitted that Met QC Criteria' label, 'No FEAR Act Data' notice, and Revision: v3.4.0. Removed the older items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now lists expanded recruitment locations, including US states (Colorado, Massachusetts, Missouri, New York, North Carolina, Rhode Island, Tennessee, Texas) and Australian regions (Queensland, South Australia, Victoria, Western Australia).SummaryDifference1%

- Check92 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.2.0 has been removed.SummaryDifference0.0%

Stay in the know with updates to ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.